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Introduction
Diabetic retinopathy is a leading cause of vision loss and blindness among working age adults. Diabetic retinopathy has been considered a microvascular disease characterized by increased vascular permeability, appearance of macular edema, and neovascularization, which usually occurs at the later stages of the disease and can lead to blindness (Antonetti et al., 2006) . However, increasing evidence has shown that the neural components of the retina are also affected, even before the detection of microvascular changes. Alterations in electroretinograms in diabetic patients and animals, and loss of colour and contrast sensitivity are early signs of neuronal dysfunction in the retina (Roy et al., 1986 , Daley et al., 1987 , Sakai et al., 1995 , Aung et al., 2013 ,Kohzaki et al., 2008 . Apoptosis and increased caspase activation in retinal neurons, as well as retinal thinning have been noted in diabetic animals (Barber et al., 1998 , Lieth et al., 2000 , Barber et al., 2005 , Whitmire et al., 2011 , Gastinger et al., 2006 , Yang et al., 2012 . In postmortem human retinas, an increase in the levels of apoptosis-inducing factor (AIF) was also reported (Abu El- Asrar et al., 2007) . Moreover, long-term exposure (7 days) of primary retinal neural cell cultures to elevated glucose concentration, to mimic chronic elevated hyperglycemia, increases cell death in by a caspase-independent mechanism, mediated by the translocation of AIF from the mitochondria to the nucleus (Santiago et al., 2007) .
Tauroursodeoxycholic acid (TUDCA) is an endogenous hydrophilic bile acid that is produced at very low levels in humans. TUDCA is formed by the conjugation of ursodeoxycholic acid (UDCA) with taurine. Several reports have demonstrated the hepatic cytoprotective effects of UDCA and TUDCA, with UDCA being widely used in clinical applications such as for the treatment of primary biliary cirrhosis and various other cholestatic disorders (Maillette de Buy Wenniger and Beuers, 2010).
Interestingly, it has been proven that TUDCA is neuroprotective in a variety of experimental systems including models of neurodegenerative disorders such as Alzheimer's and Huntington's, as well as against damage induced by ischemia and hemorrhagic stroke (McLean, 1997 , Keene et al., 2002 , Ramalho et al., 2008 , Viana et al., 2009 , Fernandez-Sanchez et al., 2011 . The protective effects of TUDCA are considered to be mainly due to its ability to inhibit apoptosis by reducing Bax translocation to mitochondrial membrane, cytochrome c release from mitochondria to cytoplasm, caspase activation and DNA and nuclear fragmentation (Amaral et al., 2009) . Besides these antiapoptotic properties, TUDCA can also function as anti-inflammatory, immunomodulatory and antioxidant agent (Amaral et al., 2009) , and activates the PI3-K/Akt-dependent survival pathway , Amaral et al., 2009 Regarding retinal diseases, TUDCA greatly slowed retinal degeneration in light-induced retinal degeneration and rd10 mice. Retinal function was improved in mice treated with TUDCA, and retinas of TUDCA-treated mice had thicker outer nuclear layers, more photoreceptor cells, and more fully-developed photoreceptor outer segments. TUDCA effects were explained by dramatic suppression of apoptosis in both models (Boatright et al., 2006) . Subsequent studies, confirmed that TUDCA protects retinal damage induced by light and oxidative stress in animal models of retinitis pigmentosa (Phillips et al., 2008 , Fernandez-Sanchez et al., 2011 , Oveson et al., 2011 . Finally, TUDCA showed neuroprotective effects on photoreceptor cells in an experimental retinal detachment model, which were associated with decreased oxidative stress and caspase activity (Mantopoulos et al., 2011) . Recently, TUDCA was shown to reduce endoplasmic reticulum stress, prevented apoptosis, and reduced cone degeneration in a mouse model of Leber congenital amaurosis (Zhang et al., 2000) . Interestingly, TUDCA ameliorated the obesity that accompanies retinal degeneration in a mouse 6 model of Bardet-Biedl syndrome (BBS) type 1, an autosomal recessive ciliopathy that causes severe retinal degeneration in humans (Drack et al., 2011) .
Since hyperglycemia, the hallmark of diabetes, is considered to play a central role in retinal cell dysfunction and degeneration, underlying the progression of diabetic retinopathy, the purpose of this study was to investigate for the first time the potential neuroprotective effects of TUDCA in rat retinal neurons against cell death induced by elevated glucose concentration.
Experimental Procedures

Primary cultures of rat retinal neural cells
All procedures involving animals were conducted in accordance with the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in ophthalmic and vision research.
Retinal cell cultures were prepared as previously described (Santiago et al., 2006a glucose; pH 7.4). The retinas were digested with 0.05% trypsin (w/v) for 10 min at 37°C. After dissociation, the cells were pelleted by centrifugation and resuspended in Eagle's minimum essential medium (MEM) supplemented with 26 mM NaHCO 3 , 25 mM HEPES, 10% heat-inactivated fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 μg/ml). The cells were plated at a density of 2x10 6 cell/cm 2 on poly-D-lysine (0.1 mg/ml)-coated plates. The cells were maintained at 37°C in a humidified atmosphere of 5% CO 2 /air. After 2 days in culture, the cells were incubated with 25 mM D-glucose (yielding a total 30 mM glucose) or with 25 mM D-mannitol (plus 5 mM glucose), which was used as an osmotic control, and maintained for further 7 days. The concentration of glucose in control conditions was 5 mM (control). These conditions are identical to those described previously (Santiago et al., 2007) . TUDCA (100 μM) was added at culture day two, and every other day.
Annexin-V FITC staining
The loss of plasma membrane asymmetry is one of the earliest features in the After washing, the cells were permeabilized with 0.2% Triton X-100 in PBS for 5 min.
The cells were rinsed and incubated with the biotinylated nucleotides and the enzyme
Terminal deoxynucleotidyl Transferase (TdT) for 1 h at 37°C. After rinsing with PBS to remove unincorporated nucleotides, the nuclei were counterstained with DAPI, and the preparations were mounted with Glycergel mounting medium. The preparations were visualized using a Zeiss LSM 710 confocal microscope, and at least 15 random fields were counted in each preparation.
Preparation of total, mitochondrial and nuclear fractions
Total, mitochondrial and nuclear fractions were prepared according our previous reports (Santiago et al., 2006b , Santiago et al., 2007 .
Total extracts
Cells were washed twice with ice-cold PBS and then lysed and homogenized with 150 mM NaCl, 50 mM Tris, 5 mM EGTA, 1% Triton X-100, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS) supplemented with complete-mini protease inhibitor cocktail tablets and 1 mM DTT. The lysates were sonicated and then centrifuged at 16100×g for 10 min at 4°C. The resulting supernatant was collected and stored at -80°C until use.
Mitochondrial extracts
Cells were washed in ice-cold sucrose buffer, containing (250 mM sucrose, 20 mM HEPES/KOH (pH 7.4), 1 mM EGTA, and 1 mM EDTA. Cell extracts were obtained in ice-cold sucrose buffer supplemented with 1 mM DTT, 100 μM PMSF, 1 μg/ml chymostatin, 1 μg/ml leupeptin, 1 μg/ml antiparin, and 1 μg/ml pepstatin A. Lysates were homogenized and centrifuged (4°C) at 500×g for 12 min to pellet the nuclei and cell debris. The supernatant was further centrifuged at 12000×g for 20 min. The resulting pellet (mitochondrial fraction) was resuspended in supplemented sucrose buffer and the samples were stored at -80°C until use.
Nuclear extracts
Cells were washed in ice-cold PBS and extracts were obtained using buffer A (10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA) supplemented with 1 mM DTT and 0.4% Nonidet P-40. The lysates were placed on ice for 30 min and then centrifuged at 15800×g for 5 min at 4 °C. The pellet was resuspended in buffer B (20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA), supplemented with 1 mM DTT and 10% glycerol, and incubated for 60 min on ice. Then, the samples were sonicated and centrifuged at 15800×g for 5 min at 4 °C. The supernatant containing the nuclear fraction was collected, and then stored at -80 °C until use.
Western blot
The protein concentration of each sample was determined by the bicinchoninic acid protein assay (Pierce Biotechnology, USA), following denaturation with 6x concentrated sample buffer (0.5 M Tris-HCl, 30% glycerol, 10% SDS, 0.6 M DTT, 0.02% bromophenol blue) at 95ºC, for 5 min. Equivalent amounts of protein (40 μg or 15 μg 10 for AIF detection from mitochondrial fraction or nuclear fraction, respectively) were used for western blot analysis. Proteins were separated on 8% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred electrophoretically to PVDF membranes. The membranes were blocked for 1 h at room temperature, in Tris buffered saline (in mM: 137 NaCl, 20 Tris-HCl; pH 7.6) containing 0.1% Tween-20 (TBS-T) and 5% skimmed milk. The membranes were incubated with the mouse anti-AIF antibody (1:1000), overnight at 4°C. After washing for 1 h in TBS-T with 0.5% skimmed milk, the membranes were incubated for 1 h at room temperature with an alkaline phosphatase-linked secondary antibody (rabbit anti-mouse IgG, 1:10000 in TBS-T with 1% skimmed milk). The membranes were processed for detection of AIF using the ECF substrate. Chemifluorescent signal was detected on an imaging system (Typhoon FLA 9000, GE Healthcare, Chalfont St. Giles, UK) and quantification was performed using Image Quant 5.0 software (Molecular Dynamics, Amersham Biosciences, Uppsala, Sweden).
To control for protein loading, the membranes were reprobed with a mouse anti-α-tubulin (1:3000) or with a mouse anti-lamin B (1:60).
Immunocytochemistry
Cells were washed twice with PBS and fixed with 4% paraformaldehyde with 4% sucrose for 10 min at room temperature. Cells were rinsed twice in PBS and then 
Detection of reactive oxygen species (ROS)
The production of ROS was evaluated using 2',7'-dichlorodihydrofluorescein diacetate 
Protein-bound carbonyl determination
For derivatization of carbonyl-containing proteins, equal amounts of proteins (total extracts) were mixed with an equal volume of 10 mM 2,4-dinitrophenylhydrazine (DNPH) in 10% trifluoroacetic acid and incubated at room temperature for 15 min. The reaction was stopped by precipitation of proteins with 20% trichloroacetic acid. The pellet was washed with ethylacetate-ethanol (1:1) to remove free DNPH. Next, the pellet was solubilized with Laemmli buffer (15.6 mM Tris-HCl pH 6.8, 2.5% glycerol, 0.5% SDS, 1.25% 2-β-mercaptoetanol, 0.01% bromophenol blue).
The DNP binding sites of the oxidized proteins were specifically detected using an anti-DNP antibody by dot blot. Briefly, 2 μl of the protein carbonyl-DNPH derivatives were loaded on a nitrocellulose membrane at each dot. Membranes were then incubated at 37°C for 40 min, to fix proteins to the membrane. After blocking the membrane with TBS-T containing 5% (w/v) skimmed milk, during 1 h at room temperature, the membranes were incubated with a goat anti-DNP primary antibody (1:2000, in TBS-T 12 solution with 5% skimmed milk) for 1 h at room temperature. The membranes were washed in TBS-T, and then incubated for 1 h at room temperature, with an alkaline phosphatase-linked rabbit anti-goat IgG secondary antibody (1:10000), in TBS-T containing 1% (w/v) skimmed milk, followed by washing in TBS-T. Protein immunoreactive dots were then visualized using ECF substrate, and fluorescence was detected on an imaging system (Typhoon FLA 9000, GE Healthcare, Chalfont St.
Giles, UK). Digital quantification of the densitometry of the bands was performed using Image Quant 5.0 software (Molecular Dynamics, Amersham Biosciences, Uppsala, Sweden).
Statistical analysis
Data are expressed as mean±SEM. Statistical significance was determined by analysis of variance (ANOVA), followed by Dunnett's or Bonferroni's post-hoc tests, as indicated in the figure legends.
RESULTS
TUDCA prevents retinal neural cell death induced by elevated glucose concentration
Previously, using the same cell culture conditions, we found that elevated glucose concentration induces cell death by a mechanism independent of caspase activation (Santiago et al., 2007) . Since TUDCA has neuroprotective properties, we investigated whether TUDCA could protect retinal neurons from cell death induced by elevated glucose concentration.
Therefore, to quantify cell death by apoptosis at an early stage ( Figure 1A 
TUDCA prevented AIF mito-nuclear translocation induced by elevated glucose concentration
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We have previously found that long-term exposure of retinal neuronal cells to elevated glucose concentration induced the translocation of AIF from the mitochondria to the nucleus (Santiago et al., 2007) . Therefore, we investigated whether TUDCA could prevent AIF translocation induced by elevated glucose concentration.
As reported previously, elevated glucose concentration significantly decreased the protein levels of AIF in the mitochondrial fraction (Figure 2A TUDCA alone did not change AIF protein levels, both in mitochondrial or nuclear fraction, as compared with control cells. By immunocytochemistry ( Figure 2C ), we observed that AIF immunoreactivity in control cells was mainly found in the perinuclear region, while in elevated glucose-treated cells AIF immunoreactivity was also observed in the nucleus, corroborating the western data. When cells exposed to elevated glucose concentration were co-treated with TUDCA, the immunoreactivity of AIF was similar to control, confirming the western blot data.
TUDCA prevented oxidative stress induced by elevated glucose concentration
It is well established that elevated glucose concentration increases oxidative stress (Pennathur and Heinecke, 2004) and it was also reported that TUDCA protects against oxidative-stress induced retinal damage (Mantopoulos et al., 2011 , Oveson et al., 2011 . We investigated whether TUDCA could protect against oxidative stress induced by elevated glucose concentration in retinal neural cells ( Figure 3A) . ROS production was assessed by quantifying DCF fluorescence. In elevated glucose concentration-treated cells, DCF fluorescence significantly increased to 192.6±23.3% of the control (P<0.01). This effect was not due to changes in osmolarity, since DCF fluorescence in mannitol-treated cells was not significantly altered compared to control cells. Cotreatment with TUDCA significantly decreased DCF fluorescence to 145.9±9.6% of the control (P<0.05), as compared to cells exposed to elevated glucose concentration.
Protein carbonyl formation was used as an indicator of oxidized proteins ( Figure 3B ).
We found that oxidative injury to carbonyl residues significantly increased in elevated glucose-treated cells, as compared with control cells (119.9±7.1% of the control;
P<0.05). The treatment with TUDCA prevented the increase in DNP immunoreactivity, as compared to elevated glucose concentration-treated cells. In TUDCA-treated cells there were not significant changes.
DISCUSSION
In this study, we demonstrated that TUDCA prevents retinal cell death and mito-nuclear translocation of AIF induced by elevated glucose concentration.
Although diabetic retinopathy has been considered a microvascular disease, there is accumulating evidence showing that retinal neurons are also affected by diabetes (Antonetti et al., 2006 , Barber et al., 2011 , Whitmire et al., 2011 . Indeed, retinal neurons have been shown to undergo apoptosis upon diabetes (Barber et al., 1998 , Abu-El-Asrar et al., 2004 , Barber et al., 2005 . Cultured retinal neural cells were incubated with elevated glucose concentration for seven days to mimic chronic hyperglycemia, which is considered the main trigger for the development of diabetic complications as diabetic retinopathy.
TUDCA is a bile acid derivative which has been reported to modulate apoptosis and survival signaling , endoplasmic reticulum-mediated stress (Gao et al., 2011 , Xie et al., 2002 , Ozcan et al., 2006 and oxidative stress (Oveson et al., 2011) in several models of degenerative diseases. These effects may explain the neuroprotective role of TUDCA (Duan et al., 2002 , Viana et al., 2009 ). In the retina, it was demonstrated that TUDCA prevents photoreceptor degeneration in models of retinitis pigmentosa and of Leber congenital amaurosis (Phillips et al., 2008 , Fernandez-Sanchez et al., 2011 , Zhang et al., 2000 . TUDCA also ameliorated the obesity that accompanies retinal degeneration in a model of Bardet-Biedl syndrome type 1 (Drack et al., 2011) .
TUDCA directly inhibits reactive oxygen species production, thus inhibiting the collapse of the transmembrane potential and the disruption of the outer mitochondrial membrane , inhibiting cytochrome c release, thereby reducing downstream events such as caspase activation and substrate cleavage (Ramalho et al., 2008 , Amaral et al., 2009 , Viana et al., 2009 ).
Previously, we demonstrated that prolonged elevated glucose concentration, mimicking chronic hyperglycemia, induces caspase-independent cell death in retinal neural cells, through the translocation of AIF from the mitochondria to the nucleus (Santiago et al., 2007) . In the present study, TUDCA prevented AIF translocation induced by elevated glucose concentration.
The treatment of retinal neural cells exposed to elevated glucose concentration with TUDCA reduced cell death. In our model, high glucose concentration increased nuclear condensation, DNA fragmentation and the exposure of annexin V at the outer leaflet of cell membranes, which are apoptotic features, and these effects were completely prevented by TUCDA. Moreover, in the same experimental model, we demonstrated that exposure of retinal neurons to elevated glucose concentration impairs calcium homeostasis (Santiago et al., 2006b) , and it is known that the prolonged increase in intracellular calcium concentration ([Ca 2+ ] i ) cause cell dysfunction and death (Duchen, 2004) . Moreover, the increase in [Ca 2+ ] i induces mitochondrial membrane permeabilization, leading to the release of soluble intermembrane proteins, such as AIF, through the outer mitochondrial membrane (Bains et al., 2003) . Therefore, it is likely that in our model TUDCA prevents the mito-nuclear translocation of AIF by the stabilization of the mitochondrial membrane. In fact, it was demonstrated that AIF is increased in the retina of postmortem diabetic patients (Abu El-Asrar et al., 2007) , and so TUDCA could be viewed as a potential therapeutic agent for the treatment of retinal diabetic complications.
Oxidative stress is believed to play a significant role in the pathogenesis of diabetic retinopathy. The increase in oxidative stress in the retina under diabetic conditions results from a variety of abnormalities, including glucose auto-oxidation, decreased antioxidant enzyme activity, and formation of advanced glycation end products (AGEs) and interactions of AGEs with membrane receptors (Giacco and Brownlee, 2010) . In fact, it is well established that high glucose induces a sustained increase in ROS production (Pennathur and Heinecke, 2004, Wang et al., 2011) , which in turn can contribute to vascular and neuronal damage in diabetes (Tomlinson and Gardiner, 2008 (Oveson et al., 2011) . In this model, the predominant effect of TUDCA was to preserve cone cell function and structure. Since increased ROS levels can be triggered by mitochondrial dysfunction leading to an energy deficit (Kowluru and Chan, 2007) , it is possible that the antioxidant effect of TUDCA may be due to its ability in suppressing mitochondrial membrane perturbation . TUDCA was also able to preserve photoreceptors after retinal detachment, and that protective effect was associated with a decrease in oxidative stress and caspase activity (Mantopoulos et al., 2011) . In our in vitro model, cell death is independent of caspase activation (Santiago et al., 2007) ; however, TUDCA was also able to prevent cell death and translocation of AIF from the mitochondria to nucleus. To our knowledge, this is the first report showing a neuroprotective effect of TUDCA involving the inhibition of AIF translocation to the nucleus.
In conclusion, we demonstrate that TUDCA is capable of preventing cell death induced 
